Accretion Nutraveda Limited IPO Review
Neutral122-129 · SME
✦
Analyst Verdict
Accretion Nutraveda Limited IPO
Neutral
IPO at a Glance
Price Band
122-129
Issue Size
25cr
Min. Investment
₹1,29,000
Opens
2026-01-26
Closes
2026-01-28
Listing
2026-02-02
Category
SME
Key Strengths
✓Diverse Ayurvedic and nutraceutical dosage capabilities under one facility
✓Strong CDMO focus with repeat domestic and export clients
✓Multiple quality certifications, including WHO-GMP, FSSC 22000 and ISO
✓Experienced promoter-led management with hands-on operations control
✓Consistent revenue and profitability growth over recent years
Key Risks
⚠High revenue dependence on the domestic and merchant export segment
⚠The manufacturing facility is leased, not owned
⚠Business exposed to regulatory changes in the Ayurveda and nutraceutical space
⚠Dependence on a limited number of key customers
⚠Geographic revenue concentration is largely within Gujarat
Frequently Asked Questions
Should I apply for Accretion Nutraveda Limited IPO?
Based on our analysis, our rating for Accretion Nutraveda Limited IPO is: Neutral. Review the full analysis including strengths, risks, and financials on CheckIPO before making a decision.
What are the key risks of Accretion Nutraveda Limited IPO?
High revenue dependence on the domestic and merchant export segment The manufacturing facility is leased, not owned Business exposed to regulatory changes in the Ayurveda and nutraceutical space
What are the strengths of Accretion Nutraveda Limited IPO?
Diverse Ayurvedic and nutraceutical dosage capabilities under one facility Strong CDMO focus with repeat domestic and export clients Multiple quality certifications, including WHO-GMP, FSSC 22000 and ISO
What is the price band of Accretion Nutraveda Limited IPO?
The price band for Accretion Nutraveda Limited IPO is 122-129. The IPO has closed.
Full Analysis Available
Financials, DRHP breakdown, peer comparison, shareholding pattern & more